Hanne C Lie1, Jon H Loge2, Sophie D Fosså3, Hanne M Hamre3, Siri L Hess3, Anneli V Mellblom4, Ellen Ruud5, Arnstein Finset4. 1. Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. Electronic address: h.c.lie@medisin.uio.no. 2. Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. 3. National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. 4. Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway. 5. Department of Paediatric Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Abstract
OBJECTIVE: Childhood cancer survivors need information about risks of late effects to manage their health. We studied how and when adult, long-term survivors prefer to receive information about late effects. METHODS: Five focus-groups with adult survivors of childhood lymphomas who had completed routine follow-up care and participated in a preceding follow-up study (n = 34, 19 females, mean age = 39). We used thematic analysis to identify themes regarding providing late effects information. RESULTS: The survivors wanted information about late effects (symptoms, prevention and treatment), lifestyle and social security rights. Information should be tailored, carefully timed, given "face-to-face" and in written format. Many expressed ambivalence regarding receiving information as adolescents, but it was seen as essential "to know" once a late effect occurred. A "re-information" consultation about late effects around age 25 was suggested as beneficial. CONCLUSION: Although ambivalent, all survivors wanted information about late effects. They preferred individualized information, disclosed "step-by-step" and in a "re-information consultation" when reaching young adulthood. PRACTICE IMPLICATIONS: Providing information about late effects should be an on-going process across the cancer care trajectory. (Re-)Informing survivors when older would enhance their understanding of their health risks and could aid better health self-management beyond completion of follow-up care.
OBJECTIVE: Childhood cancer survivors need information about risks of late effects to manage their health. We studied how and when adult, long-term survivors prefer to receive information about late effects. METHODS: Five focus-groups with adult survivors of childhood lymphomas who had completed routine follow-up care and participated in a preceding follow-up study (n = 34, 19 females, mean age = 39). We used thematic analysis to identify themes regarding providing late effects information. RESULTS: The survivors wanted information about late effects (symptoms, prevention and treatment), lifestyle and social security rights. Information should be tailored, carefully timed, given "face-to-face" and in written format. Many expressed ambivalence regarding receiving information as adolescents, but it was seen as essential "to know" once a late effect occurred. A "re-information" consultation about late effects around age 25 was suggested as beneficial. CONCLUSION: Although ambivalent, all survivors wanted information about late effects. They preferred individualized information, disclosed "step-by-step" and in a "re-information consultation" when reaching young adulthood. PRACTICE IMPLICATIONS: Providing information about late effects should be an on-going process across the cancer care trajectory. (Re-)Informing survivors when older would enhance their understanding of their health risks and could aid better health self-management beyond completion of follow-up care.
Authors: Gisela Michel; Renée L Mulder; Helena J H van der Pal; Roderick Skinner; Edit Bárdi; Morven C Brown; Janine Vetsch; Eva Frey; Rachael Windsor; Leontien C M Kremer; Gill Levitt Journal: J Cancer Surviv Date: 2019-08-08 Impact factor: 4.442
Authors: Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein Journal: J Cancer Surviv Date: 2017-03-29 Impact factor: 4.442
Authors: Anneli V Mellblom; Live Korsvold; Arnstein Finset; Jon Loge; Ellen Ruud; Hanne C Lie Journal: J Adolesc Young Adult Oncol Date: 2015-12 Impact factor: 2.223
Authors: Hanne C Lie; Anneli V Mellblom; Mette Brekke; Arnstein Finset; Sophie D Fosså; Cecilie E Kiserud; Ellen Ruud; Jon H Loge Journal: Support Care Cancer Date: 2017-02-24 Impact factor: 3.603